WO2018159965A1 - Method for producing polyhydroxyalkanoate using 2-hydroxyisocaproate-coa transferase - Google Patents
Method for producing polyhydroxyalkanoate using 2-hydroxyisocaproate-coa transferase Download PDFInfo
- Publication number
- WO2018159965A1 WO2018159965A1 PCT/KR2018/002305 KR2018002305W WO2018159965A1 WO 2018159965 A1 WO2018159965 A1 WO 2018159965A1 KR 2018002305 W KR2018002305 W KR 2018002305W WO 2018159965 A1 WO2018159965 A1 WO 2018159965A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene encoding
- monomer
- amino acid
- polyhydroxyalkanoate
- acid sequence
- Prior art date
Links
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 title claims abstract description 102
- 229920000903 polyhydroxyalkanoate Polymers 0.000 title claims abstract description 100
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 42
- 102000004357 Transferases Human genes 0.000 title claims abstract description 28
- 108090000992 Transferases Proteins 0.000 title claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 143
- 239000000178 monomer Substances 0.000 claims abstract description 122
- 125000003118 aryl group Chemical group 0.000 claims abstract description 79
- 244000005700 microbiome Species 0.000 claims abstract description 67
- 108010010718 poly(3-hydroxyalkanoic acid) synthase Proteins 0.000 claims abstract description 35
- 150000001413 amino acids Chemical group 0.000 claims description 76
- 241000630665 Hada Species 0.000 claims description 53
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims description 52
- VOXXWSYKYCBWHO-UHFFFAOYSA-M 3-phenyllactate Chemical compound [O-]C(=O)C(O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-UHFFFAOYSA-M 0.000 claims description 32
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 claims description 30
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- LVRFTAZAXQPQHI-UHFFFAOYSA-N 2-hydroxy-4-methylvaleric acid Chemical group CC(C)CC(O)C(O)=O LVRFTAZAXQPQHI-UHFFFAOYSA-N 0.000 claims description 15
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 claims description 15
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 15
- NYHNVHGFPZAZGA-UHFFFAOYSA-N 2-hydroxyhexanoic acid Chemical compound CCCCC(O)C(O)=O NYHNVHGFPZAZGA-UHFFFAOYSA-N 0.000 claims description 14
- 229910019142 PO4 Inorganic materials 0.000 claims description 13
- 239000010452 phosphate Substances 0.000 claims description 13
- AYOLELPCNDVZKZ-UHFFFAOYSA-M 3-hydroxy-3-phenylpropionate Chemical compound [O-]C(=O)CC(O)C1=CC=CC=C1 AYOLELPCNDVZKZ-UHFFFAOYSA-M 0.000 claims description 12
- 102000003960 Ligases Human genes 0.000 claims description 12
- 108090000364 Ligases Proteins 0.000 claims description 12
- 108010035004 Prephenate Dehydrogenase Proteins 0.000 claims description 12
- 238000012258 culturing Methods 0.000 claims description 12
- 101150089463 fldH gene Proteins 0.000 claims description 11
- 108010001539 D-lactate dehydrogenase Proteins 0.000 claims description 10
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 claims description 10
- 241000589516 Pseudomonas Species 0.000 claims description 9
- 102100026105 3-ketoacyl-CoA thiolase, mitochondrial Human genes 0.000 claims description 8
- 108010003902 Acetyl-CoA C-acyltransferase Proteins 0.000 claims description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 8
- 241000252867 Cupriavidus metallidurans Species 0.000 claims description 8
- 108010008456 D-mandelate dehydrogenase Proteins 0.000 claims description 8
- 241000589774 Pseudomonas sp. Species 0.000 claims description 8
- 108091000039 acetoacetyl-CoA reductase Proteins 0.000 claims description 8
- 241000423301 Clostridioides difficile 630 Species 0.000 claims description 7
- 108010090410 L-mandelate dehydrogenase Proteins 0.000 claims description 7
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 108010042687 Pyruvate Oxidase Proteins 0.000 claims description 5
- 101150044161 tyrR gene Proteins 0.000 claims description 5
- VKVOJYUPJRVDPP-UHFFFAOYSA-N 2,2-dihydroxy-2-phenylacetic acid Chemical compound OC(=O)C(O)(O)C1=CC=CC=C1 VKVOJYUPJRVDPP-UHFFFAOYSA-N 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- 102000019259 Succinate Dehydrogenase Human genes 0.000 claims description 4
- 108010012901 Succinate Dehydrogenase Proteins 0.000 claims description 4
- 108090000340 Transaminases Proteins 0.000 claims description 4
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 108010008221 formate C-acetyltransferase Proteins 0.000 claims description 4
- 102000014898 transaminase activity proteins Human genes 0.000 claims description 4
- 102000016540 Tyrosine aminotransferases Human genes 0.000 claims description 3
- 108010042606 Tyrosine transaminase Proteins 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- OBKXEAXTFZPCHS-UHFFFAOYSA-M 4-phenylbutyrate Chemical compound [O-]C(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-M 0.000 claims 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N gamma-phenylbutyric acid Natural products OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 claims 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract description 2
- 239000004621 biodegradable polymer Substances 0.000 abstract description 2
- 241000588724 Escherichia coli Species 0.000 description 84
- VOXXWSYKYCBWHO-QMMMGPOBSA-N (S)-3-phenyllactic acid Chemical compound OC(=O)[C@@H](O)CC1=CC=CC=C1 VOXXWSYKYCBWHO-QMMMGPOBSA-N 0.000 description 49
- 210000004027 cell Anatomy 0.000 description 36
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 30
- 230000014509 gene expression Effects 0.000 description 30
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 28
- 239000008103 glucose Substances 0.000 description 28
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 27
- 239000005516 coenzyme A Substances 0.000 description 27
- 229940093530 coenzyme a Drugs 0.000 description 27
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 27
- 229920000642 polymer Polymers 0.000 description 27
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 25
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 25
- 239000013598 vector Substances 0.000 description 25
- 230000015572 biosynthetic process Effects 0.000 description 24
- 101001027074 Azotobacter chroococcum mcd 1 Flavodoxin A Proteins 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 19
- 239000002609 medium Substances 0.000 description 19
- 239000000758 substrate Substances 0.000 description 19
- 229920001577 copolymer Polymers 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 17
- 229920000728 polyester Polymers 0.000 description 17
- IWYDHOAUDWTVEP-SSDOTTSWSA-M (R)-mandelate Chemical compound [O-]C(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-M 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 108091008146 restriction endonucleases Proteins 0.000 description 13
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 12
- 230000004907 flux Effects 0.000 description 12
- 230000002503 metabolic effect Effects 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- JVNVHNHITFVWIX-KZKUDURGSA-N (E)-cinnamoyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)\C=C\C1=CC=CC=C1 JVNVHNHITFVWIX-KZKUDURGSA-N 0.000 description 7
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 7
- -1 2-hydroxybutyl Chemical group 0.000 description 7
- JVNVHNHITFVWIX-WBHAVQPBSA-N Cinnamoyl-CoA Natural products S(C(=O)/C=C/c1ccccc1)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C JVNVHNHITFVWIX-WBHAVQPBSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- JVGVDSSUAVXRDY-UHFFFAOYSA-N 3-(4-hydroxyphenyl)lactic acid Chemical compound OC(=O)C(O)CC1=CC=C(O)C=C1 JVGVDSSUAVXRDY-UHFFFAOYSA-N 0.000 description 6
- 150000001491 aromatic compounds Chemical class 0.000 description 6
- 238000000126 in silico method Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 238000012269 metabolic engineering Methods 0.000 description 6
- 230000037353 metabolic pathway Effects 0.000 description 6
- 229960005190 phenylalanine Drugs 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 108010080376 3-Deoxy-7-Phosphoheptulonate Synthase Proteins 0.000 description 5
- 241001509415 Clostridium botulinum A Species 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 241000187432 Streptomyces coelicolor Species 0.000 description 4
- 101100002724 Thermus thermophilus aroH gene Proteins 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 101150076125 aroG gene Proteins 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 101150015424 dmd gene Proteins 0.000 description 4
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 4
- 101150041530 ldha gene Proteins 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 210000003705 ribosome Anatomy 0.000 description 4
- 229920001791 ((R)-3-Hydroxybutanoyl)(n-2) Polymers 0.000 description 3
- QHHKKMYHDBRONY-RMNRSTNRSA-N 3-hydroxybutanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QHHKKMYHDBRONY-RMNRSTNRSA-N 0.000 description 3
- YHXHKYRQLYQUIH-UHFFFAOYSA-M 4-hydroxymandelate Chemical compound [O-]C(=O)C(O)C1=CC=C(O)C=C1 YHXHKYRQLYQUIH-UHFFFAOYSA-M 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- 241001430312 Amycolatopsis orientalis Species 0.000 description 3
- 101710194359 Cinnamoyl-CoA:phenyllactate CoA-transferase Proteins 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 101100462488 Phlebiopsis gigantea p2ox gene Proteins 0.000 description 3
- 241001149408 Rhodotorula graminis Species 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 101150014383 adhE gene Proteins 0.000 description 3
- 101150005925 aspC gene Proteins 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000013611 chromosomal DNA Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 101150018523 frdB gene Proteins 0.000 description 3
- 238000000099 in vitro assay Methods 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 101150023849 pheA gene Proteins 0.000 description 3
- 101150060030 poxB gene Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 101150028338 tyrB gene Proteins 0.000 description 3
- JNJCEALGCZSIGB-UHFFFAOYSA-N 2-hydroxy-4-phenylbutanoic acid Chemical compound OC(=O)C(O)CCC1=CC=CC=C1 JNJCEALGCZSIGB-UHFFFAOYSA-N 0.000 description 2
- AYOLELPCNDVZKZ-UHFFFAOYSA-N 3-hydroxy-3-phenylpropionic acid Chemical compound OC(=O)CC(O)C1=CC=CC=C1 AYOLELPCNDVZKZ-UHFFFAOYSA-N 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 101100259583 Bacillus subtilis (strain 168) tyrS2 gene Proteins 0.000 description 2
- 101000644386 Brevibacillus parabrevis Phenylalanine racemase [ATP-hydrolyzing] Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101000906861 Chondromyces crocatus ATP-dependent tyrosine adenylase Proteins 0.000 description 2
- 241000193163 Clostridioides difficile Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 108010020056 Hydrogenase Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 101100297400 Rhizobium meliloti (strain 1021) phaAB gene Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009585 enzyme analysis Methods 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VIWKEBOLLIEAIL-FBMOWMAESA-N lactoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VIWKEBOLLIEAIL-FBMOWMAESA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 229950009215 phenylbutanoic acid Drugs 0.000 description 2
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- NBPUSGBJDWCHKC-UHFFFAOYSA-M sodium 3-hydroxybutyrate Chemical compound [Na+].CC(O)CC([O-])=O NBPUSGBJDWCHKC-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 229910021654 trace metal Inorganic materials 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 229910019614 (NH4)6 Mo7 O24.4H2 O Inorganic materials 0.000 description 1
- WHBMMWSBFZVSSR-GSVOUGTGSA-N (R)-3-hydroxybutyric acid Chemical compound C[C@@H](O)CC(O)=O WHBMMWSBFZVSSR-GSVOUGTGSA-N 0.000 description 1
- LVRFTAZAXQPQHI-YFKPBYRVSA-N (S)-2-hydroxy-4-methylpentanoic acid Chemical compound CC(C)C[C@H](O)C(O)=O LVRFTAZAXQPQHI-YFKPBYRVSA-N 0.000 description 1
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-L 5-[(3-carboxylato-4-nitrophenyl)disulfanyl]-2-nitrobenzoate Chemical compound C1=C([N+]([O-])=O)C(C(=O)[O-])=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C([O-])=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-L 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 1
- 102000006732 Citrate synthase Human genes 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193470 Clostridium sporogenes Species 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 102000010079 Coenzyme A-Transferases Human genes 0.000 description 1
- 108010077385 Coenzyme A-Transferases Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241001522878 Escherichia coli B Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910004844 Na2B4O7.10H2O Inorganic materials 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 101150012394 PHO5 gene Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 101100463818 Pseudomonas oleovorans phaC1 gene Proteins 0.000 description 1
- 241000232299 Ralstonia Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- GJLUGLKKLPHWPU-SYLRIUJSSA-N S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (E)-4-methylpent-2-enethioate Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/C(C)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 GJLUGLKKLPHWPU-SYLRIUJSSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 101100280476 Streptococcus pneumoniae (strain ATCC BAA-255 / R6) fabM gene Proteins 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 101100492609 Talaromyces wortmannii astC gene Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 101150116772 aatA gene Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- FIXLYHHVMHXSCP-UHFFFAOYSA-H azane;dihydroxy(dioxo)molybdenum;trioxomolybdenum;tetrahydrate Chemical compound N.N.N.N.N.N.O.O.O.O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O[Mo](O)(=O)=O.O[Mo](O)(=O)=O.O[Mo](O)(=O)=O FIXLYHHVMHXSCP-UHFFFAOYSA-H 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 101150100742 dapL gene Proteins 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001400 expression cloning Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 101150027052 hmo gene Proteins 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 101150046540 phaA gene Proteins 0.000 description 1
- 101150110984 phaB gene Proteins 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- SHJSMZQAXRYSOA-UFTIVKCMSA-N s-[2-[3-[[(2r)-4-[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 2-hydroxy-2-phenylethanethioate Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C(O)C1=CC=CC=C1 SHJSMZQAXRYSOA-UFTIVKCMSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
- C08G63/688—Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Definitions
- the present invention relates to a method for producing a polyhydroxyalkanoate containing an aromatic monomer or a long-chain 2-hydroxyalkanoate (2-HA) as a monomer, more particularly 2-hydroxyiso.
- a gene encoding a caproate-CoA transferase and a gene encoding a polyhydroxyalkanoate synthetase have been introduced, and have a polyhydroxyalkanoate generating ability containing an aromatic monomer or a long chain 2-HA as a monomer.
- PHAs Polyhydroxyalkanoates
- These polymers are thermoplastics with biodegradable and biocompatible properties, and can have similar industrial properties as petroleum-based polymers, enabling a variety of industrial biomedical applications and resulting from renewable resources (Lee, SY Biotechnol. Bioeng . 49: 1 1996).
- PHAs are classified into short-chain-length PHAs (SCL-PHAs) having a short carbon number and medium-chain-length PHAs (MCL-PHAs) having a long carbon number according to side chain lengths.
- SCL-PHAs short-chain-length PHAs
- MCL-PHAs medium-chain-length PHAs
- Suitable examples of copolymers of certain two monomers include poly PHB-co-3-hydroxyhexanoate (Brandl et al., Int. J. Biol. Macromol . 11:49, 1989; A mos & McInerey, Arch Microbiol. , 155: 103, 1991; US 5,292,860).
- Biosynthesis of PHA undergoes a process in which hydroxy acids are converted to hydroxyacyl-CoA by CoA-transferase or CoA-ligase, and the converted hydroxyacyl-CoA is polymerized by PHA synthase.
- the activity for 2-hydroxyacyl-CoA is much lower than for 3-hydroxyacyl-CoA.
- the inventors of Pseudomonas sp. 6-19 PHA synthase was genetically engineered to use lactyl-CoA, a type of 2-hydroxyacyl-CoA, as a substrate (WO08 / 062996; Yang et al., Biotechnol.
- PhaC1ps6-19 has a wide variety of substrate specificities and converts various types of 2-hydroxy acids to 2-hydroxyacyl-CoA because it can use lactyl-CoA, a type of 2-hydroxyacyl-CoA, as a substrate. Developing a feasible system would allow the synthesis of new PHAs containing different types of 2-hydroxy acids.
- the present inventors have made intensive efforts to develop a method for biosynthesis of PHA containing a new 2-hydroxy acid.
- the enzyme converts 2-hydroxy acid using acetyl-CoA into 2-hydroxyacyl-CoA.
- screening and using the enzyme it was confirmed that it is possible to produce a variety of 2-hydroxyacyl-CoA under in vitro conditions, it was confirmed that it is possible to produce a variety of PHA by using this, to complete the present invention .
- An object of the present invention is to provide a recombinant microorganism having a polyhydroxyalkanoate producing ability containing an aromatic monomer or a long chain 2-HA as a monomer.
- Another object of the present invention to provide a method for producing a polyhydroxyalkanoate containing an aromatic monomer or a long chain 2-HA as a monomer using the recombinant microorganism.
- the present invention provides a gene encoding 2-hydroxyisocaproate-CoA transferase and a gene encoding polyhydroxyalkanoate synthase in a microorganism having acetyl-CoA generating ability from a carbon source.
- a recombinant microorganism having a polyhydroxyalkanoate-producing ability which is introduced and contains an aromatic monomer or a long chain 2-HA as a monomer.
- the present invention also comprises the steps of (a) culturing the recombinant microorganism to produce a polyhydroxyalkanoate containing an aromatic monomer or a long chain 2-HA as a monomer; And (b) obtaining a polyhydroxyalkanoate containing the produced aromatic monomer or long chain 2-HA as a monomer.
- the present invention also relates to a gene encoding 2-hydroxyisocaproate-CoA transferase, a gene encoding polyhydroxyalkanoate synthase, DAHP (3-de) in a microorganism having acetyl-CoA generating ability from a carbon source.
- Oxy-D-arabino-heptulsonate-7-phosphate) synthetase gene encoding corismate mutase / prephenate dehydrogenase and D-lactate dehydrogenase
- a recombinant microorganism having a polyhydroxyalkanoate-producing ability containing a phenyl lactate as a monomer and amplified gene is provided.
- the present invention also comprises the steps of (a) culturing the recombinant microorganism, to produce a polyhydroxyalkanoate containing phenyl lactate as a monomer; And (b) obtaining a polyhydroxyalkanoate containing the produced phenyllactate as a monomer. It provides a method for producing polyhydroxyalkanoate containing a phenyllactate as a monomer.
- the present invention also relates to a gene encoding 2-hydroxyisocaproate-CoA transferase, a gene encoding polyhydroxyalkanoate synthase, DAHP (3-de) in a microorganism having acetyl-CoA generating ability from a carbon source.
- Oxy-D-arabino-heptulsonate-7-phosphate) synthetase gene encoding corismate mutase / prephenate dehydrogenase and D-lactate dehydrogenase
- a recombinant microorganism having hydroxyalkanoate producing ability.
- the present invention also comprises the steps of (a) culturing the recombinant microorganism to produce a polyhydroxyalkanoate containing mandelate as a monomer; And (b) obtaining a polyhydroxyalkanoate containing the produced mandelate as a monomer, thereby providing a method for preparing polyhydroxyalkanoate containing a mandelate as a monomer.
- Figure 1 shows the biosynthetic metabolic pathway of the aromatic polyester according to the present invention
- A is the metabolic pathway when using FldA (cinnamoyl-CoA: phenyllactate CoA-transferase)
- B is HadA (2- Metabolic pathways using hydroxyisocaproate-CoA transferase).
- Figure 2 shows the result of comparing the amino acid sequence homology of HadA and FldA.
- Figure 4 shows that HadA uses acetyl-CoA as CoA donor, mandelate, 4-hydroxymandelate, phenyllactate, 4-hydroxyphenyllactate, 2-hydroxy-4-phenylbutyrate, 3-hydroxy
- acetyl-CoA as CoA donor
- mandelate 4-hydroxymandelate
- phenyllactate 4-hydroxyphenyllactate
- 2-hydroxy-4-phenylbutyrate 3-hydroxy
- the conversion of oxy-3-phenylpropionate and 4-hydroxy benzoic acid to the corresponding CoA derivatives was confirmed by LC-MS analysis after in vitro enzyme assay.
- Figure 6 shows the results of increasing the production of D-phenyl lactate by performing metabolic analysis according to in silico genome scale metabolic flux analysis.
- Figure 7 shows the results of the analysis of poly (3HB-co-D-phenyl lactate) produced by E. coli XB201TBAL.
- 10A and 10B show the production of poly (3HB-co-D-phenyllactate) by fed-batch fermentation of E. coli XB201TBAL strain expressing AroGfbr, PheAfbr, FldH, HadA and PhaC1437 in MR medium containing 3HB.
- C and d are fed by a fed-batch fermentation of the E. coli XB201TBAL strain expressing PhaAB under the AroGfbr, PheAfbr, FldH, HadA, PhaC1437 and BBa_J23114 promoters without addition of 3HB to obtain poly (3HB-co-D-phenyllactate).
- Aromatic polyesters are essential plastics produced mainly from petroleum.
- an aromatic polyester or a long chain 2-hydroxyalkanoate is prepared from glucose by metabolic engineering E. coli expressing polyhydroxyalkanoate (PHA) synthase and coenzyme A (CoA) transferase.
- PHA polyhydroxyalkanoate
- CoA coenzyme A
- cinnamoyl-CoA phenyllactate CoA-transferase (FldA) and 4-Cuma have been identified by in vitro assays to produce PHAs containing phenyllactate as aromatic polyesters.
- an E. coli engineered to have an optimal metabolic pathway for D-phenyllactate production in order to prepare an E. coli engineered to have an optimal metabolic pathway for D-phenyllactate production, over-expression of feedback resistance aroG, pheA and fldH genes in tyrR deficient E. coli, and competitive metabolism
- the pathways (pflB, poxB, adhE and frdB) were deleted and the tyrB and aspC genes were further deleted following in silico genome scale metabolic flux analysis.
- the metabolically engineered Escherichia coli produced 1.62 g / L of D-phenyllactate.
- the present invention in a microorganism having the ability to produce acetyl-CoA from a carbon source, a gene encoding 2-hydroxyisocaproate-CoA transferase and a gene encoding a polyhydroxyalkanoate synthase is introduced
- the present invention relates to a recombinant microorganism having a polyhydroxyalkanoate generating ability containing an aromatic monomer or a long chain 2-HA as a monomer.
- the long chain 2-HA means 2-hydroxyalkanoate having 6 to 8 carbon atoms.
- the aromatic monomer or long-chain 2-HA monomer is 2-hydroxyisocaproate, 2-hydroxyhexanoate, 2-hydroxyoctanoate, phenyl lactate, 2-hydroxy-4 It may be characterized in that it is selected from the group consisting of -phenylbutyrate, 3-hydroxy-3-phenylpropionate, 4-hydroxybenzoic acid and mandelate.
- the polyhydroxyalkanoate synthase is Ralstonia eutropha, Pseudomonas, Bacillus and Pseudomonas sp. It may be characterized as a PHA synthase derived from a strain selected from the group consisting of 6-19 or a variant enzyme of PHA synthase having an amino acid sequence selected from:
- amino acid sequence comprising one or more variants selected from the group consisting of E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K and Q481R in the amino acid sequence of SEQ ID NO: 2;
- Amino acid sequence (C1335) wherein E130D, S325T, L412M, S477G and Q481M are mutated in amino acid sequence of SEQ ID NO: 2;
- the 2-hydroxyisocaproate-CoA transferase may be characterized as hadA derived from Clostridium difficile 630.
- the 2-hydroxyisocaproate-CoA transferase may be characterized by using acetyl-CoA as CoA donor.
- the microorganism of the present invention is a gene encoding ⁇ -ketothiolase involved in 3-hydroxybutyryl-CoA biosynthesis and a gene encoding acetoacetyl-CoA reductase in order to produce a polymer without externally supplying 3HB. It may be characterized by being introduced further.
- the present invention comprises the steps of (a) culturing the recombinant microorganism to produce a polyhydroxyalkanoate containing an aromatic monomer or long chain 2-HA as a monomer; And (b) obtaining a polyhydroxyalkanoate containing the produced aromatic monomer or long chain 2-HA as a monomer. It relates to a method for producing a canoate.
- Pct Propionyl-CoA transferase
- Pctcp Propionyl-CoA transferase
- polyesters comprising 2-hydroxy acids such as glycolic acid, lactic acid, 2-hydroxybutyl acid, 2-hydroxyisovalorate and various hydroxy acids. Since it is used, Pct540 can be said to have a broad substrate spectrum with respect to carbon number and hydroxyl position.
- Pct540 was found to have no catalytic activity for phenyllactate and mandelate, and therefore, in the present invention, for the production of aromatic copolymers, a novel CoA-transition capable of activating CoA derivatives corresponding to aromatic compounds We wanted to find an enzyme.
- Cinnamoyl-CoA Phenyllactate CoA-transferase (FldA) of Clostridium sporogenes has been reported to convert phenyllactate to phenyllactyl-CoA using cinnamoyl-CoA as a CoA donor (Dickert, S. et al., Eur. J. Biochem . 267: 3874, 2000). Cinnamoyl-CoA is a non-natural metabolite of Escherichia coli. Therefore, to confirm the use of acetyl-CoA, a rich metabolite in cells, as a CoA donor, Clostridium botulinum A str. FldA from ATCC 3502 was tested. However, C. botulinum A str. It was confirmed that FldA of ATCC 3502 does not have the catalytic activity of generating phenyllactyl-CoA using acetyl-CoA as CoA donor.
- CoA ligase (4CL) plays an important role in phenylpropanoid metabolism, which produces precursors of plant secondary metabolites such as lignin, flavonoids and phytoalexin (Kaneko, M. et al, J. Bacteriol. 185: 20, 2003). Therefore, in one aspect of the present invention, a biosynthetic pathway for synthesizing cinnamoyl-CoA from cinnamate was designed by introducing 4CL.
- the 4CL variant was used to convert cinnamates to cinnamoyl-CoA and cinnamoyl-CoA was used as CoA donor of FldA for phenyllactyl-CoA formation.
- phenyllactyl-CoA was successfully synthesized by sequential reaction of 4CL and FldA in vitro .
- 4CL and FldA could be used for the production of phenyllactyl-CoA and that it could be used for producing aromatic polyesters.
- 4-hydroxyphenyllactate another promising aromatic monomer, was also converted to 4-hydroxyphenyllactyl-CoA by in vitro sequential reaction of 4CL variant with FldA.
- Pseudomonas sp. MBEL 6-19 PHA synthase (PhaCPs6-19) variants were expressed in Escherichia coli XL1-Blue overexpressing AroGfbr, PAL, 4CL, FldA and Pct540.
- the prepared recombinant strain was cultured in MR medium to which 20 g / L glucose, 1 g / L D-phenyllactate and 1 g / L sodium 3-hydroxybutyrate (3HB) were added.
- Sodium 3-hydroxybutyrate (3HB) was converted by Pct540 to 3HB-CoA, which is the preferred substrate of PhaC, and was added to enhance the production of the polymer because it allows the production of sufficient amounts of PHA.
- E. coli XL1-Blue which expresses different PHA synthase variants, can produce varying amounts of poly (D-lactate-co-3HB-co-D-phenyllactate) with different monomer compositions.
- PhaC1437 containing four amino acid substitutions (E130D, S325T, S477G and Q481K) in the PhaC variant was poly (18.3 mol% D-lactate-co-76.9 mol% 3HB-co-4.8 mol% D-phenyl Lactate) was produced at 7.8% by weight of the dry cell weight to identify the most suitable PhaC variant.
- E. coli was manipulated to generate D- phenyllactate from glucose in vivo .
- Biosynthesis of aromatic compounds begins with the synthesis of 3-deoxy-D-arabino-heptulsonate-7-phosphate (DAHP), which is combined with phosphoenolpyruvate (PEP) by DAHP synthase. It is produced by the condensation of ellithrose-4-phosphate (E4P). The resulting DAHP is converted to phenylpyruvate (PPA) followed by D-lactate dihydrogenase (FldH) to D-phenyllactate (FIG. 1). Metabolic pathways for aromatic compound biosynthesis are known to be complexly controlled by various inhibitory mechanisms.
- AroGfbr AroG (D146N)] and PheAfbr [PheA (T326P)] were constructed to release feedback inhibition by L-phenylalanine (Zhou, HY et al., Bioresour. Technol. 101: 4151, 2010; Kikuchi, Y. et al., Appl. Environ.Microbiol. 63: 761, 1997).
- Escherichia coli XL1-Blue expressing FldH of ATCC 3502 produced 0.372 g / L of D-phenyllactate from 15.2 g / L of glucose.
- Overexpression of PAL, 4CL, FldA, Pct540 and PhaC1437 of the strain was poly (16.8 mol% D-lactate-co-80.8 mol% 3HB-co-1.6 mol% D-phenyllactate-co-0.8 mol% D -4-hydroxyphenyllactate) was increased to 12.8% by weight of the dry cell weight.
- an enzyme having a broad spectrum of aromatic substrate was found using acetyl-CoA as CoA donor.
- An array similarity analysis was performed to identify homologous enzymes for FldA and 2-isocaprenoyl-CoA: 2-hydroxyisocapronate of Clostridium difficile having at least 48% amino acid sequence identity with FldA among various FldAs of different origins.
- CoA-transferase (HadA) was screened (FIG. 2).
- HadA is an enzyme known to convert CoA into 2-hydroxyisocaproate using isocaprenoyl-CoA as a CoA donor
- the present invention investigated whether HadA can use acetyl-CoA as a CoA donor ( 3).
- In vitro enzyme analysis showed that HadA was able to activate phenyllactate as phenyllactyl-CoA using acetyl-CoA as a CoA donor (FIG. 4).
- HadA also contains mandelate, 4-hydroxymandelate, phenyllactate, 4-hydroxyphenyllactate, 2-hydroxy-4-phenylbutyrate, 3-hydroxy-3-phenylpropionate and 4 It was confirmed through LC-MS analysis after in vitro assay that hydroxy benzoic acid can be converted into the corresponding CoA derivative (FIGS. 4 and 5). Therefore, HadA has the potential to produce various aromatic polyesters more efficiently by using acetyl-CoA as a CoA donor.
- E. coli XL1-Blue strain without TyrR deletion To eliminate a path conflict with D-phenyllactate biosynthesis, in E. coli XBT, poxB (a gene encoding pyruvate oxidase), a pyruvate oxidase), pflB (a gene encoding pyruvate formate lyase), Escherichia coli XB201T was constructed by deleting adhE (gene encoding acetaldehyde dehydrogenase / alcohol dehydrogenase) and frdB (gene encoding fumarate reductase).
- adhE gene encoding acetaldehyde dehydrogenase / alcohol dehydrogenase
- frdB Gene encoding fumarate reductase
- coli XB201T strains expressing AroGfbr, PheAfbr and FldH produced 0.55 g / L of D-phenyllactate from 15.7 g / L of glucose, indicating a 10% higher yield than E. coli XBT.
- Escherichia coli XB201TBAL expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA was incubated in a medium containing 20 g / L glucose and 1 g / L sodium 3HB to obtain poly (52.1 mol% 3HB-co-47.9 mol% D-phenyllactate).
- Poly 52.1 mol% 3HB-co-47.9 mol% D-phenyllactate
- the present invention provides a gene encoding 2-hydroxyisocaproate-CoA transferase, a gene encoding polyhydroxyalkanoate synthase, in a microorganism having acetyl-CoA generating ability from a carbon source, Gene encoding DAHP (3-deoxy-D-arabino-heptulsonate-7-phosphate) synthase, gene encoding corismate mutase / prephenate dehydrogenase and D-lactate di
- the present invention relates to a recombinant microorganism having a polyhydroxyalkanoate-producing ability, in which a gene encoding a hydrogenase has been introduced and containing phenyllactate as a monomer.
- the 2-hydroxyisocaproate-CoA transferase may be characterized as hadA derived from Clostridium difficile 630, the hydroxyalkanoate synthase is Ralstonia eutropha, Pseudomonas, Bacillus and Pseudomonas sp . It may be characterized as a PHA synthase derived from a strain selected from the group consisting of 6-19 or a variant enzyme of PHA synthase having an amino acid sequence selected from:
- amino acid sequence comprising one or more variants selected from the group consisting of E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K and Q481R in the amino acid sequence of SEQ ID NO: 2;
- Amino acid sequence (C1335) wherein E130D, S325T, L412M, S477G and Q481M are mutated in amino acid sequence of SEQ ID NO: 2;
- the gene encoding the DAHP (3-deoxy-D-arabino-heptulsonate-7-phosphate) synthase is a gene encoding the amino acid sequence represented by SEQ ID NO: 8
- the gene encoding the corismate mutase / prephenate dehydrogenase may be a gene encoding an amino acid sequence represented by SEQ ID NO: 9, wherein the D-lactate dehydrogeze
- the gene encoding the claw may be a gene encoding the amino acid sequence represented by SEQ ID NO: 10.
- the gene encoding the introduced D-lactate dehydrogenase may be characterized as being a fldH gene that replaces the ldhA gene.
- the microorganism of the present invention is a gene encoding ⁇ -ketothiolase involved in 3-hydroxybutyryl-CoA biosynthesis and a gene encoding acetoacetyl-CoA reductase in order to produce a polymer without externally supplying 3HB. It may be characterized by being introduced further.
- the recombinant microorganism is a tyrR gene, a gene encoding pyruvate oxidase, a gene encoding pyruvate formate lyase, a gene encoding acetaldehyde dehydrogenase, a gene encoding fumarate reductase, tyrosine amino
- a gene encoding the transferase and a gene encoding the aspartic acid aminotransferase may be deleted.
- the present invention relates to a method for preparing polyhydroxyalkanoate containing a phenyllactate as a monomer.
- mandelate was tested using monomers. This is because polymandelate, the single polymer of mandelate, is a pyrolysis resistant polymer having a relatively high Tg of 100 ° C., while the material properties are similar to polystyrene. Polymandelate is chemically synthesized by ring-opening polymerization of cyclic dimer of mandelate produced in the petroleum industry.
- Escherichia coli XB201TBAL expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA was cultured in a medium containing 1 g / L sodium 3HB and 0.5 g / L D-mandelate to obtain poly (55.2 mol% 3HB-co-43 mol% D-phenyl Lactate-co-1.8 mol% D-mandelate) was prepared at a 11.6 wt% content of dry cell weight (FIGS. 8 a, b).
- an aromatic copolymer including D-mandelate was successfully prepared using D-mandelate as a substrate, and then, to produce D-mandelate in vivo by metabolic engineering.
- HmaS Amycolatopsis orientalis-derived hydroxymandelate synthetase
- S. coelicolor Hydrolysis of Amycolatopsis orientalis-derived hydroxymandelate synthetase (HmaS), S. coelicolor, in E. coli XB201TBAL expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA to produce an aromatic copolymer comprising D-mandelate from glucose Roxymandelate oxidase (Hmo) and D-mandelate dehydrogenase (Dmd) from Rhodotorula graminis were expressed.
- Hmo glucose Roxymandelate oxidase
- Dmd D-mandelate dehydrogenase
- the present invention provides a gene encoding 2-hydroxyisocaproate-CoA transferase, a gene encoding polyhydroxyalkanoate synthase, in a microorganism having acetyl-CoA generating ability from a carbon source, Gene encoding DAHP (3-deoxy-D-arabino-heptulsonate-7-phosphate) synthase, gene encoding corismate mutase / prephenate dehydrogenase and D-lactate di Genes encoding hydrogenase, genes encoding hydroxymandelate synthase, genes encoding hydroxymandelate oxidase and genes encoding D-mandelate dehydrogenase have been introduced.
- the present invention relates to a recombinant microorganism having a polyhydroxyalkanoate producing ability contained as a monomer.
- the 2-hydroxyisocaproate-CoA transferase may be characterized as hadA derived from Clostridium difficile 630, the hydroxyalkanoate synthase is Ralstonia eutropha, Pseudomonas, Bacillus and Pseudomonas sp . It may be characterized as a PHA synthase derived from a strain selected from the group consisting of 6-19 or a variant enzyme of PHA synthase having an amino acid sequence selected from:
- amino acid sequence comprising one or more variants selected from the group consisting of E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K and Q481R in the amino acid sequence of SEQ ID NO: 2;
- Amino acid sequence (C1335) wherein E130D, S325T, L412M, S477G and Q481M are mutated in amino acid sequence of SEQ ID NO: 2;
- the gene encoding the DAHP (3-deoxy-D-arabino-heptulsonate-7-phosphate) synthase is a gene encoding the amino acid sequence represented by SEQ ID NO: 8
- the gene encoding the corismate mutase / prephenate dehydrogenase may be a gene encoding an amino acid sequence represented by SEQ ID NO: 9, wherein the D-lactate dehydrogeze
- the gene encoding the claw may be a gene encoding the amino acid sequence represented by SEQ ID NO: 10.
- the gene encoding the hydroxymandelate synthetase may be a gene encoding the amino acid sequence represented by SEQ ID NO: 11
- the gene encoding the hydroxymandelate oxidase May be a gene encoding an amino acid sequence represented by SEQ ID NO: 12
- the gene encoding the D-mandelate dehydrogenase may be a gene encoding an amino acid sequence represented by SEQ ID NO: 13 Can be.
- the microorganism of the present invention is a gene encoding ⁇ -ketothiolase involved in 3-hydroxybutyryl-CoA biosynthesis and a gene encoding acetoacetyl-CoA reductase in order to produce a polymer without externally supplying 3HB. It may be characterized by being introduced further.
- the present invention provides a method for producing a polyhydroxyalkanoate containing mandelate as a monomer by culturing the recombinant microorganism; And (b) obtaining a polyhydroxyalkanoate containing the produced mandelate as a monomer.
- 2-hydroxyisocapro which is a long-chain 2-HA monomer 8 (2HIC), 2-hydroxyhexanoate (2HH) and 2-hydroxyoctanoate (2HO) were used as monomers to confirm polymer production capacity.
- 2-hydroxyisocaproate It was confirmed that a copolymer containing 2-hydroxyhexanoate or 2-hydroxyoctanoate was produced, and as the concentration of 2-HA contained in the medium increased, the mole fraction of the monomer contained in the copolymer increased. was confirmed (Table 4, Table 5 and Table 6).
- the present invention provides a recombinant microorganism having the ability to produce polyhydroxyalkanoate containing the aromatic monomer or the long-chain 2-HA as a monomer, in a further aspect, 2-hydroxyisocaproate, 2-hydroxy.
- a bacterial platform system has been developed for the production of various aromatic polyesters.
- the aromatic polymer production system of the present invention identifies CoA-transferases having a new broad substrate range for activating aromatic compounds into their CoA derivatives, and in vivo, PHA synthase variants capable of polymerizing their aromatic CoA derivatives.
- the pathway to overproduce aromatic monomers was established through the design and optimization of metabolism.
- HadA or related enzymes
- PHA synthetase can be engineered to accommodate the desired aromatic monomer.
- the bacterial platform system developed in the present invention can contribute to establishing a bioprocess for the production of aromatic polyesters from renewable non-food biomass.
- vector refers to a DNA preparation containing a DNA sequence operably linked to a suitable regulatory sequence capable of expressing DNA in a suitable host.
- the vector may be a plasmid, phage particles, or simply a potential genomic insert. Once transformed into the appropriate host, the vector can replicate and function independently of the host genome, or in some cases can be integrated into the genome itself. Since plasmids are the most commonly used form of current vectors, “plasmid” and “vector” are sometimes used interchangeably in the context of the present invention. For the purposes of the present invention, it is preferred to use plasmid vectors.
- Typical plasmid vectors that can be used for this purpose include (a) a replication initiation point that allows for efficient replication to include hundreds of plasmid vectors per host cell, and (b) host cells transformed with the plasmid vector. It has a structure comprising an antibiotic resistance gene and (c) a restriction enzyme cleavage site into which foreign DNA fragments can be inserted. Although no appropriate restriction enzyme cleavage site is present, the use of synthetic oligonucleotide adapters or linkers according to conventional methods facilitates ligation of the vector and foreign DNA.
- the vector should be transformed into the appropriate host cell.
- preferred host cells are prokaryotic cells.
- Suitable prokaryotic host cells include E. coli DH5 ⁇ , E. col JM101, E. coli K12, E. coli W3110, E. coli X1776, E. coli XL-1Blue (Stratagene), E. coli B, E. coli B21, and the like. It includes. However, E. coli strains such as FMB101, NM522, NM538 and NM539 and other prokaryotic species and genera may also be used. In addition to the aforementioned E.
- strains of the genus Agrobacterium such as Agrobacterium A4, bacilli, such as Bacillus subtilis, Salmonella typhimurium or Serratia marghesen Still other enterobacteria such as marcescens and various Pseudomonas strains can be used as host cells.
- Prokaryotic transformation can be readily accomplished using the calcium chloride method described in section 1.82 of Sambrook et al., Supra. Alternatively, electroporation (Neumann et al., EMBO J., 1: 841, 1982) can also be used for transformation of these cells.
- an expression vector known in the art may be used, and it is preferable to use a pET family vector (Novagen).
- a pET family vector Novagen
- histidine groups are bound to the ends of the expressed protein, and thus the protein can be effectively purified.
- a general method known in the art may be used, and specifically, it may be separated by a chromatographic method using Ni-NTA His-binding resin (Novagen).
- the recombinant vector may be characterized in that the pET-SLTI66, the host cell may be characterized in that E. coli or Agrobacterium.
- expression “expression control sequence” in the present invention means a DNA sequence essential for the expression of a coding sequence operably linked in a particular host organism.
- regulatory sequences include promoters for performing transcription, any operator sequence for regulating such transcription, sequences encoding suitable mRNA ribosomal binding sites, and sequences that control the termination of transcription and translation.
- suitable control sequences for prokaryotes include promoters, optionally operator sequences, and ribosomal binding sites.
- Eukaryotic cells include promoters, polyadenylation signals, and enhancers. The factor that most influences the amount of gene expression in the plasmid is the promoter.
- an SR ⁇ promoter As the promoter for high expression, an SR ⁇ promoter, a promoter derived from cytomegalovirus, and the like are preferably used.
- any of a wide variety of expression control sequences can be used in the vector.
- Useful expression control sequences include, for example, early and late promoters of SV40 or adenovirus, lac system, trp system, TAC or TRC system, T3 and T7 promoters, major operator and promoter regions of phage lambda, fd code protein Regulatory region of, promoter for 3-phosphoglycerate kinase or other glycolysis enzymes, promoters of the phosphatase such as Pho5, promoter of yeast alpha-crossing system and gene expression of prokaryotic or eukaryotic cells or viruses Other sequences known to modulate and various combinations thereof.
- the T7 promoter can be usefully used to express the proteins of the invention in E. coli.
- Nucleic acids are "operably linked” when placed in a functional relationship with other nucleic acid sequences. This may be genes and regulatory sequence (s) linked in such a way as to allow gene expression when appropriate molecules (eg, transcriptional activating proteins) bind to regulatory sequence (s).
- the DNA for a pre-sequence or secretion leader is operably linked to the DNA for the polypeptide when expressed as a shear protein that participates in the secretion of the polypeptide;
- a promoter or enhancer is operably linked to a coding sequence when it affects the transcription of the sequence;
- the ribosomal binding site is operably linked to a coding sequence when it affects the transcription of the sequence;
- the ribosomal binding site is operably linked to a coding sequence when positioned to facilitate translation.
- "operably linked” means that the linked DNA sequence is in contact, and in the case of a secretory leader, is in contact and present within the reading frame.
- enhancers do not need to touch. Linking of these sequences is performed by ligation (linking) at convenient restriction enzyme sites. If such sites do not exist, synthetic oligonucleotide adapters or linkers according to conventional methods are used.
- heterologous DNA refers to heterologous DNA, which is DNA not naturally found in host cells. Once the expression vector is in the host cell, it can replicate independently of the host chromosomal DNA and several copies of the vector and the inserted (heterologous) DNA can be produced.
- the gene must be operably linked to transcriptional and translational expression control sequences that function in the selected expression host.
- the expression control sequence and the gene of interest are included in one expression vector including the bacterial selection marker and the replication origin. If the host cell is a eukaryotic cell, the expression vector must further comprise an expression marker useful in the eukaryotic expression host.
- Host cells transformed or transfected with the expression vectors described above constitute another aspect of the present invention.
- transformation means introducing DNA into a host so that the DNA is replicable as an extrachromosomal factor or by chromosomal integration.
- transfection means that the expression vector is accepted by the host cell whether or not any coding sequence is actually expressed.
- the relative strength of the sequence, the controllability, and the compatibility with the DNA sequences of the present invention should be considered, particularly with regard to possible secondary structures.
- Single cell hosts may be selected from a host for the selected vector, the toxicity of the product encoded by the DNA sequence of the invention, the secretory properties, the ability to accurately fold the protein, the culture and fermentation requirements, the product encoded by the DNA sequence of the invention from the host. It should be selected in consideration of factors such as the ease of purification.
- one skilled in the art can select a variety of vector / expression control sequence / host combinations capable of expressing the DNA sequences of the invention in fermentation or large scale animal culture.
- a binding method binding method
- a panning method a panning method
- a film emulsion method and the like can be applied.
- E. coli was used as a recombinant microorganism, but any microorganism that produces acetyl-CoA from a carbon source can be used without limitation, and includes genus Alcaligenes, Pseudomonas, Escherichia, Ralstonia genus, Bacillus genus, Corynebacterium and the like can be used.
- Recombinant strains, plasmids and primers used or produced in the present invention are shown in Tables 1-3.
- Acetyl-CoA was used as CoA donor to find enzymes with broad spectrum of aromatic substrates.
- An array similarity assay was performed to identify homologous enzymes for FldA and 2-isocaprenoyl-CoA: 2-hydroxyisocaproate of Clostridium difficile having at least 48% amino acid sequence identity with FldA among various FldAs of different origins.
- CoA-transferase (HadA, SEQ ID NO: 1) was screened (FIG. 2).
- a recombinant vector containing a gene encoding HadA the chromosomal DNA of Clostridium diffsile 630 strain was used as a template, and PCR was performed using HadA-hisF and HadA-hisR primers to obtain a C terminus.
- the prepared his_HadA fragment was treated with restriction enzymes (NdeI and NotI) to the pET22b plasmid undergoing strong gene expression of the T7 promoter, followed by T4 DNA ligase, and his_HadA fragment digested with restriction enzyme and pET22b plasmid was conjugated to prepare a recombinant plasmid pET22b_hisHadA (FIG. 2).
- restriction enzymes NdeI and NotI
- the pET22b_hisHadA was introduced into Escherichia coli XL1-Blue (Stratagene Cloning Systems, USA), cultured, and IPTG was added to induce HadA expression, followed by Ni-NTA spin kit (Quiagen, Germany) using His-tag. HadA was purified from the culture medium at (Fig. 3a).
- Figure 5 shows the molecular formula of the CoA conversion reaction of the various substrates that HadA can convert.
- E. coli was engineered to produce D-phenyllactate from glucose in vivo.
- Biosynthesis of aromatic compounds begins with the synthesis of 3-deoxy-D-arabino-heptulsonate-7-phosphate (DAHP), which is combined with phosphoenolpyruvate (PEP) by DAHP synthase. It is produced by the condensation of erythrose-4-phosphate (E4P). The resulting DAHP is converted to phenylpyruvate (PPA) followed by D-lactate dihydrogenase (FldH) to D-phenyllactate (FIG. 1). Metabolic pathways for aromatic compound biosynthesis are known to be complexly controlled by various inhibitory mechanisms.
- the feedback inhibition resistance mutants AroGfbr [AroG (D146N)] and PheAfbr [PheA (T326P)] were constructed to release feedback inhibition by L-phenylalanine (Zhou, HY et al., Bioresour. Technol . 101: 4151, 2010; Kikuchi, Y. et al., Appl. Environ.Microbiol . 63: 761, 1997).
- E. coli XL1-Blue expressing the FldH of ATCC 3502 was constructed.
- 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase gene (aroG), a feedback inhibition resistance mutation, was constructed using primers AroG-F and AroG-R to construct pKM212-AroGfbr.
- PCR product was prepared using the plasmid pTyr-a (Na, D. et al., Nature Biotechnol. 31: 170, 2013) as a template, and the PCR product was purified using pKM212 using restriction enzymes (EcoRI / HidIII).
- PKM212-AroGfbr was constructed in conjunction with -MCS (Park, SJ et al., Metab. Eng . 20:20, 2013).
- the pKM212-AroGfbrPheAfbr plasmid was constructed as follows. First, 991 bp DNA fragments from genomic DNA of Escherichia coli were amplified by PCR using primers PheA-F and PheAmut-R of a single mutated base (T976G). Second, a 200 bp DNA fragment was amplified from genomic DNA of Escherichia coli using a single mutated base (A976C) and PheAmut-F primer of PheA-R.
- a DNA fragment of 1161bp was amplified by the primers PheA-F and PheA-R by overlap PCR.
- the PCR product was linked to pKM212-AroGfbr prepared above using restriction enzyme (HindIII).
- fldH D-lactate dehydrogenase
- Codon usage frequency of the fldH gene was carried out using E. coli-optimized E. coli codon-optimized fldH gene using primers FldH-F and FldH-R and pUC57-FldHopt (GenScript, Piscataway, NJ, USA) as a template.
- the PCR product was linked with pTrc99A (Pharmacia, Biotech, Sweden) using restriction enzymes (BamHI / HindIII) to prepare pTrc-FldH.
- the fldH gene coupled to the trc promoter and rrnB terminator was amplified by PCR using primers Trc-F and Ter-R using pTrc-FldH as a template.
- the amplified PCR product was linked with pACYC184KS (Korean Patent Publication No. 2015-0142304) using restriction enzymes (XhoI / SacI) to obtain pACYC-FldH.
- PKM212-AroGfbrPheAfbr and pACYC-FldH prepared above were introduced into E. coli XL1-Blue to prepare recombinant E. coli expressing AroGfbr, PheAfbr and FldH.
- the Escherichia coli produced 0.372 g / L of D-phenyllactate when incubated in MR medium containing 15.2 g / L of glucose.
- the MR medium comprises 6.67 g KH 2 PO 4, 4 g (NH 4) 2 HPO 4, 0.8 g MgSO 4 .7H 2 O, 0.8 g citrate and 5 ml of trace metal solution, the trace metal solution being 0.5 M HCl: 10 g FeSO 4 ⁇ 7H 2 O, 2g CaCl 2, 2.2g ZnSO 4 .7H 2 O, 0.5g MnSO 4 .4H 2 O, 1g CuSO 4 .5H 2 O, 0.1g (NH 4) 6 Mo 7 O 24 .4H 2 O and 0.02 g Na 2 B 4 O 7 .10H 2 O.
- E. coli XL1-Blue strains expressing the AroGfbr, PheAfbr and FldH producing small amounts of D-phenyllactate (0.372 g / L) from glucose were subjected to metabolic engineering. Yield was increased through.
- E. coli XBT strains expressing AroGfbr, PheAfbr and FldH, which deleted TyrR, a dual transcription regulator that regulates aromatic amino acid biosynthesis were prepared.
- the E. coli XBT strain was cultured in MR medium containing 16.4 g / L glucose and produced 0.5 g / L D-phenyllactate, which was 30% higher than the E. coli XL1-Blue strain without tyrR. Productivity was shown.
- poxB a gene encoding pyruvate oxidase
- pflB a gene encoding pyruvate formate lyase
- adhE acetaldehyde dehydrogenase / alcohol dehydrogenase
- E. coli XB201T strain produced 0.55 g / L of D-phenyllactate from 15.7 g / L of glucose, indicating a 10% higher yield than E. coli XBT.
- metabolic analysis was performed according to in silico genome scale metabolic flux analysis to further increase D-phenyllactate production.
- the tyrB gene encoding tyrosine aminotransferase and the aspC gene encoding aspartic acid aminotransferase were removed from the E. coli XB201T strain, and L-phenylalanine biosynthesis was reduced to D-phenyllactate. The carbon flow to the furnace was enhanced.
- the E. coli XB201TBA strain produced as a result of the in silico flux response analysis produced 1.62 g / L of D-phenyllactate from 18.5 g / L of glucose, which greatly increased the yield of E. coli expressing AroGfbr, PheAfbr and FldH. It is 4.35 times higher than D-phenyllactate production of XL1-Blue strain.
- chromosomal DNA of Clostridium difficile 630 strain was used as a template, and PCR was performed using HadA-sbF and HadA-ndR primers to prepare a recombinant vector.
- a hadA gene segment encoding isocaproate-CoA transferase was constructed.
- the amplified PCR product was linked with p619C1437-pct540 (Yang, TH et al. Biotechnol Bioeng 105: 150, 2010) using restriction enzymes (SbfI / NdeI) to obtain p619C1437-HadA.
- P619C1437-HadA prepared above was introduced into E. coli XB201TBAL to prepare recombinant E. coli expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA.
- the E. coli was cultured in MR medium containing 20 g / L glucose and 1 g / L sodium 3HB to convert poly (52.1 mol% 3HB-co-47.9 mol% D-phenyllactate) to a content of 15.8% by weight of the dry cell weight.
- Produced (FIG. 7).
- Fed-batch also produced poly (52.3 mol% 3HB-co-47.7 mol% D-phenyllactate) at a 24.3 wt% content of dry cell weight (FIGS. 10a, b).
- Escherichia coli XB201TBAL expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA was incubated in MR medium containing 1 g / L sodium 3HB and 0.5 g / L D-mandelate, resulting in poly (55.2 mol% 3HB-co-43.0 mol % D-phenyllactate-co-1.8 mol% D-mandelate) was prepared in an amount of 11.6% by weight of the dry cell weight (FIG. 8a, b), containing D-mandelate using D-mandelate as a substrate. Aromatic polymers have been successfully prepared.
- D-mandelate was produced in vivo by metabolic engineering.
- Amycolatopsis orientalis-derived hydroxymandelate synthetase (HmaS), S. coelicolor, hydroxymandelate oxidase in E. coli XB201TBAL expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA to produce D-mandelate from glucose (Hmo) and D-mandelate dehydrogenase (Dmd) from Rhodotorula graminis.
- hmaS hydroxymandelic acid synthase gene from A. orientalis was used and the codon was cloned into a synthetic vector in Escherichia coli to construct plasmid pUC57-HmaSopt (GenScript, Piscataway, NJ, USA). ).
- the pUC57-HmaSopt was linked to pKM212-MCS using restriction enzymes (EcoRI / KpnI).
- EcoRI / KpnI restriction enzymes
- To construct pKM212-HmaSHmo S. coelicolor's hydroxymandelate oxidase gene (hmo) was synthesized by codon-optimized hmo gene (GenScript, Piscataway, NJ, USA), and primers Hmo-F and Hmo-R were used. Amplified by PCR. The PCR product was linked to pKM212-HmaS using restriction enzymes (KpnI / BamHI) to prepare pKM212-HmaSHmo.
- pUC57-Dmd containing the E. coli codon optimized dmd gene was synthesized to generate pKM212-HmaSHmoDmd (GenScript, Piscataway, NJ, USA) and E. coli codon optimized by PCR with primers Dmd-F and Dmd-R R. graminis D-mandelate dehydrogenase gene (dmd) was amplified.
- the PCR product was linked to pKM212-HmaSHmo using restriction enzymes (BamHI / SbfI) to prepare pKM212-HmaSHmoDmd.
- PKM212-HmaSHmoDmd prepared above was introduced into E. coli XB201TBAL expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA, to prepare a recombinant strain having mandelate production capacity.
- Aromatic polymer production was confirmed using 3-hydroxy-3-phenylpropionate (3HPh) as another possible aromatic monomer.
- Escherichia coli XB201TBAL strains were cultured in a medium containing 20 g / L glucose, 0.5 g / L 3-hydroxy-3-phenylpropionic acid and 1 g / L sodium 3HB to obtain a poly (33.3 mol% 3HB-co-18.0 mol% D-phenyl Lactate-co-48.7 mol% 3HPh) was confirmed to produce 14.7 wt% of the dry cell weight (Figure 8c, d).
- Copolymers containing hydroxyisocaproate, 2-hydroxyhexanoate or 2-hydroxyoctanoate were produced.
- concentration of 2-HA contained in the medium increases, the mole fraction of the monomer contained in the copolymer increases (Table 4, Table 5 and Table 6).
- PhaAB Five different plasmids expressing PhaAB were constructed under five promoters of different intensities (SEQ ID NOs: 89-93) and introduced into XB201TBAL strains expressing AroGfbr, PheAfbr, FldH, PhaC1437 and HadA.
- pH-stat culture of E. coli XB201TBAL strain expressing PhaAB under the AroGfbr, PheAfbr, FldH, HadA, PhaC1437 and BBa_J23114 promoters was performed without 3HB feeding.
- poly (67.6 mol% 3HB-co-32.4 mol% D-phenyllactate) having a polymer content of 43.8 wt% of dry cell weight was produced at 2.5 g / L (FIG. 10C, d).
- the ldhA gene of the E. coli XB201TBA chromosome was replaced with the fldH gene to further optimize the production of aromatic polyhydroxyalkanoate to optimize the gene expression system.
- the native promoter of the ldhA gene was replaced with a strong trc promoter to increase the expression of the fldH gene.
- a fed-batch fermentation was performed using a pulse feeding method to supply glucose.
- coli XB201TBAF strains expressing PhaAB under the AroGfbr, PheAfbr, FldH, HadA, PhaC1437, and BBa_J23114 promoters are poly (69.1 mol% 3HB-co-38.1 mol% D-phenyllactate) having a polymer content of 55.0% by weight of dry cell weight.
- PHA Polyhydroxyalkanoate
- monomer composition were determined by GC or GC-MS.
- the collected cells were washed three times with distilled water, and then lyophilized for 24 hours, and the PHAs of the lyophilized cells were converted to the corresponding hydroxymethyl esters by acid catalyzed metanolysis.
- the resulting methyl ester was obtained using GC (Agilent 6890N, Agilent, USA) equipped with an Agilent 7683 autoinjector, frame ionization detector and fused silica capillary column (ATTM-Wax, 30 m, ID 0.53 mm, thickness 1.20 ⁇ m, Alltech, USA). Analyzed.
- the polymer was extracted by chloroform extraction and purified in cells using solvent extraction.
- the structure, molecular weight and thermal properties of the polymers were measured using nuclear magnetic resonance (NMR), gel permeation chromatography (GPC) and differential scanning calorimetry (DSC), respectively.
- Figure 7 shows the results of the analysis of the poly (3HB-co-D-phenyl lactate) produced by E. coli XB201TBAL
- Figure 8 shows the poly (3HB-co-D- produced by E. coli XB201TBAL Phenyllactate-co-D-mandelate) is shown.
- a biodegradable polymer containing an aromatic monomer or a long chain 2-HA as a monomer can be produced.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (32)
- 탄소원으로부터 아세틸-CoA 생성능을 가지는 미생물에서, 2-하이드록시이소카프로에이트-CoA 전이효소를 코딩하는 유전자 및 폴리하이드록시알카노에이트 합성효소를 코딩하는 유전자가 도입되어 있으며, 방향족 단량체 또는 장사슬 2-HA를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.In microorganisms having the ability to produce acetyl-CoA from a carbon source, a gene encoding 2-hydroxyisocaproate-CoA transferase and a gene encoding polyhydroxyalkanoate synthetase are introduced, and an aromatic monomer or a long chain 2 A recombinant microorganism having a polyhydroxyalkanoate generating ability containing -HA as a monomer.
- 제1항에 있어서, 상기 폴리하이드록시알카노에이트 합성효소는 Ralstonia eutropha, Pseudomonas, Bacillus 및 Pseudomonas sp. 6-19으로 구성된 군에서 선택되는 균주 유래의 PHA synthase 또는 하기에서 선택되는 아미노산 서열을 가지는 PHA synthase의 변이효소인 것을 특징으로 하는 재조합 미생물:According to claim 1, wherein the polyhydroxyalkanoate synthase is Ralstonia eutropha, Pseudomonas, Bacillus and Pseudomonas sp. Recombinant microorganisms characterized in that the PHA synthase derived from a strain selected from the group consisting of 6-19 or a variant enzyme of PHA synthase having an amino acid sequence selected from the following:서열번호 2의 아미노산 서열에서 E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K 및 Q481R로 구성되는 군으로부터 선택되는 하나 이상의 변이를 포함하는 아미노산 서열;An amino acid sequence comprising one or more variants selected from the group consisting of E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K and Q481R in the amino acid sequence of SEQ ID NO: 2;서열번호 2의 아미노산 서열에서 E130D, S325T, L412M, S477G 및 Q481M이 변이된 아미노산 서열(C1335);Amino acid sequence (C1335) wherein E130D, S325T, L412M, S477G and Q481M are mutated in amino acid sequence of SEQ ID NO: 2;서열번호 2의 아미노산 서열에서 E130D, S477F 및 Q481K가 변이된 아미노산 서열(C1310); 및Amino acid sequence (C1310) wherein E130D, S477F and Q481K are mutated in the amino acid sequence of SEQ ID NO: 2; And서열번호 2의 아미노산 서열에서 E130D, S477F 및 Q481R이 변이된 아미노산 서열(C1312).The amino acid sequence of E130D, S477F and Q481R having a mutated amino acid sequence of SEQ ID NO: 2 (C1312).
- 제1항에 있어서, 상기 2-하이드록시이소카프로에이트-CoA 전이효소는 Clostridium difficile 630 유래의 hadA인 것을 특징으로 하는 재조합 미생물. The recombinant microorganism of claim 1, wherein the 2-hydroxyisocaproate-CoA transferase is hadA derived from Clostridium difficile 630.
- 제1항 또는 제2항에 있어서, 상기 2-하이드록시이소카프로에이트-CoA 전이효소는 아세틸-CoA를 CoA 공여체로 사용하는 것을 특징으로 하는 재조합 미생물. The recombinant microorganism of claim 1 or 2, wherein the 2-hydroxyisocaproate-CoA transferase uses acetyl-CoA as a CoA donor.
- 제1항에 있어서, 상기 방향족 단량체 또는 장사슬 2-HA 단량체는 2-하이드록시이소카프로에이트, 2-하이드록시헥사노에이트, 2-하이드록시옥타노에이트, 페닐락테이트, 2-하이드록시-4-페닐부티레이트, 3-하이드록시-3-페닐프로피오네이트, 4-하이드록시벤조산 및 만델레이트로 구성된 군에서 선택되는 것을 특징으로 하는 재조합 미생물.The method of claim 1, wherein the aromatic monomer or long-chain 2-HA monomer is 2-hydroxyisocaproate, 2-hydroxyhexanoate, 2-hydroxyoctanoate, phenyllactate, 2-hydroxy- Recombinant microorganism, characterized in that selected from the group consisting of 4-phenylbutyrate, 3-hydroxy-3-phenylpropionate, 4-hydroxybenzoic acid and mandelate.
- 제1항에 있어서, β-케토티올레이즈를 코딩하는 유전자와 아세토아세틸-CoA 리덕테이즈를 코딩하는 유전자가 추가로 도입되어 있는 것을 특징으로 하는 재조합 미생물.The recombinant microorganism according to claim 1, wherein a gene encoding β-ketothiolase and a gene encoding acetoacetyl-CoA reductase are further introduced.
- 다음 단계를 포함하는 방향족 단량체 또는 장사슬 2-HA를 단량체로 함유하는 폴리하이드록시알카노에이트의 제조방법:A process for preparing polyhydroxyalkanoate containing as an monomer an aromatic monomer or a long chain 2-HA comprising the following steps:(a) 제1항 내지 제6항 중 어느 한 항의 재조합 미생물을 배양하여 방향족 단량체 또는 장사슬 2-HA를 단량체로 함유하는 폴리하이드록시알카노에이트를 생성시키는 단계; 및(a) culturing the recombinant microorganism of any one of claims 1 to 6 to produce a polyhydroxyalkanoate containing an aromatic monomer or a long chain 2-HA as a monomer; And(b) 상기 생성된 방향족 단량체 또는 장사슬 2-HA를 단량체로 함유하는 폴리하이드록시알카노에이트를 수득하는 단계.(b) obtaining a polyhydroxyalkanoate containing the produced aromatic monomer or long chain 2-HA as a monomer.
- 제7항에 있어서, 상기 재조합 미생물을 방향족 단량체 또는 장사슬 2-HA를 단량체로 함유하는 배지에서 배양하는 것을 특징으로 하는 폴리하이드록시알카노에이트의 제조방법.The method for producing polyhydroxyalkanoate according to claim 7, wherein the recombinant microorganism is cultured in a medium containing an aromatic monomer or a long chain 2-HA as a monomer.
- 제7항에 있어서, 상기 방향족 단량체 또는 장사슬 2-HA를 단량체는 2-하이드록시이소카프로에이트, 2-하이드록시헥사노에이트, 2-하이드록시옥타노에이트, 페닐락테이트, 2-하이드록시-4-페닐부티레이트, 3-하이드록시-3-페닐프로피오네이트, 4-하이드록시벤조산 및 만델레이트로 구성된 군에서 선택되는 것을 특징으로 하는 폴리하이드록시알카노에이트의 제조방법.The method of claim 7, wherein the aromatic monomer or the long-chain 2-HA monomer is 2-hydroxyisocaproate, 2-hydroxyhexanoate, 2-hydroxyoctanoate, phenyl lactate, 2-hydroxy A process for producing polyhydroxyalkanoate, characterized in that it is selected from the group consisting of -4-phenylbutyrate, 3-hydroxy-3-phenylpropionate, 4-hydroxybenzoic acid and mandelate.
- 탄소원으로부터 아세틸-CoA 생성능을 가지는 미생물에서, 2-하이드록시이소카프로에이트-CoA 전이효소를 코딩하는 유전자, 폴리하이드록시알카노에이트 합성효소를 코딩하는 유전자, DAHP(3-데옥시-D-아라비노-헵툴로소네이트-7-인산) 합성효소를 코딩하는 유전자, 코리스메이트 뮤타아제/프레페네이트 디하이드로게네이즈를 코딩하는 유전자 및 D-락테이트 디하이드로게네이즈를 코딩하는 유전자가 도입되어 있고, 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.In microorganisms having the ability to produce acetyl-CoA from a carbon source, a gene encoding 2-hydroxyisocaproate-CoA transferase, a gene encoding polyhydroxyalkanoate synthase, DAHP (3-deoxy-D-ara) The gene encoding the Vino-heptulsonate-7-phosphate) synthetase, the gene encoding the corismate mutase / prephenate dehydrogenase and the gene encoding the D-lactate dehydrogenase were introduced. And a recombinant microorganism having a polyhydroxyalkanoate-generating ability, containing phenyl lactate as a monomer.
- 제10항에 있어서, 상기 2-하이드록시이소카프로에이트-CoA 전이효소는 Clostridium difficile 630 유래의 hadA인 것을 특징으로 하는 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물. The recombinant microorganism having polyhydroxyalkanoate-producing ability according to claim 10, wherein the 2-hydroxyisocaproate-CoA transferase is hadA derived from Clostridium difficile 630.
- 제10항에 있어서, 상기 폴리하이드록시알카노에이트 합성효소는 Ralstonia eutropha, Pseudomonas, Bacillus 및 Pseudomonas sp. 6-19으로 구성된 군에서 선택되는 균주 유래의 PHA synthase 또는 하기에서 선택되는 아미노산 서열을 가지는 PHA synthase의 변이효소인 것을 특징으로 하는 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물:The method of claim 10, wherein the polyhydroxyalkanoate synthase is Ralstonia eutropha, Pseudomonas, Bacillus and Pseudomonas sp. PHA synthase derived from a strain selected from the group consisting of 6-19 or a polyhydroxyalkanoate producing ability containing a phenyl lactate as a monomer, characterized in that the mutant enzyme of PHA synthase having an amino acid sequence selected below Recombinant Microorganisms:서열번호 2의 아미노산 서열에서 E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K 및 Q481R로 구성되는 군으로부터 선택되는 하나 이상의 변이를 포함하는 아미노산 서열;An amino acid sequence comprising one or more variants selected from the group consisting of E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K and Q481R in the amino acid sequence of SEQ ID NO: 2;서열번호 2의 아미노산 서열에서 E130D, S325T, L412M, S477G 및 Q481M이 변이된 아미노산 서열(C1335);Amino acid sequence (C1335) wherein E130D, S325T, L412M, S477G and Q481M are mutated in amino acid sequence of SEQ ID NO: 2;서열번호 2의 아미노산 서열에서 E130D, S477F 및 Q481K가 변이된 아미노산 서열(C1310); 및Amino acid sequence (C1310) wherein E130D, S477F and Q481K are mutated in the amino acid sequence of SEQ ID NO: 2; And서열번호 2의 아미노산 서열에서 E130D, S477F 및 Q481R이 변이된 아미노산 서열(C1312).The amino acid sequence of E130D, S477F and Q481R having a mutated amino acid sequence of SEQ ID NO: 2 (C1312).
- 제10항에 있어서, 상기 DAHP(3-데옥시-D-아라비노-헵툴로소네이트-7-인산) 합성효소를 코딩하는 유전자는 서열번호 8으로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The gene encoding the DAHP (3-deoxy-D-arabino-heptulsonate-7-phosphate) synthase is a gene encoding an amino acid sequence represented by SEQ ID NO: 11. A recombinant microorganism having a polyhydroxyalkanoate-generating ability, containing a phenyl lactate as a monomer.
- 제10항에 있어서, 상기 코리스메이트 뮤타아제/프레페네이트 디하이드로게네이즈를 코딩하는 유전자는 서열번호 9으로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The poly-containing monomer of phenyl lactate according to claim 10, wherein the gene encoding the corismate mutase / prephenate dehydrogenase is a gene encoding an amino acid sequence represented by SEQ ID NO: 9. Recombinant microorganism having hydroxyalkanoate producing ability.
- 제10항에 있어서, 상기 D-락테이트 디하이드로게네이즈를 코딩하는 유전자는 서열번호 10으로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The polyhydroxyalkano containing a phenyl lactate as a monomer according to claim 10, wherein the gene encoding the D-lactate dehydrogenase is a gene encoding an amino acid sequence represented by SEQ ID NO: 10. Recombinant microorganisms having the ability to produce.
- 제10항에 있어서, 상기 D-락테이트 디하이드로게네이즈를 코딩하는 유전자는 fldH 유전자인 것을 특징으로 하는 페닐락테이트를 단량체로 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The recombinant microorganism having a polyhydroxyalkanoate-producing ability with phenyllactate as a monomer according to claim 10, wherein the gene encoding the D-lactate dehydrogenase is a fldH gene.
- 제10항에 있어서, β-케토티올레이즈를 코딩하는 유전자와 아세토아세틸-CoA 리덕테이즈를 코딩하는 유전자가 추가로 도입되어 있는 것을 특징으로 하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The recombinant microorganism having a polyhydroxyalkanoate-producing ability according to claim 10, wherein a gene encoding β-ketothiolase and a gene encoding acetoacetyl-CoA reductase are further introduced.
- 제10항에 있어서, tyrR 유전자, 피루브산 산화효소를 코딩하는 유전자, 피루브산 포메이트 리아제를 코딩하는 유전자, 아세트알데히드 탈수소효소를 코딩하는 유전자, 푸마레이트 리덕테이즈를 코딩하는 유전자, 티로신 아미노전이효소를 코딩하는 유전자, 및 아스파라긴산 아미노전이효소를 코딩하는 유전자로 구성된 군에서 선택되는 하나 이상의 유전자가 결실되어 있는 것을 특징으로 하는 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The tyrR gene, a gene encoding pyruvate oxidase, a gene encoding pyruvate formate lyase, a gene encoding acetaldehyde dehydrogenase, a gene encoding fumarate reductase, a tyrosine aminotransferase A recombinant microorganism having a polyhydroxyalkanoate-producing ability containing a phenyl lactate as a monomer, wherein at least one gene selected from the group consisting of a gene encoding the gene and a gene encoding aspartic acid aminotransferase is deleted.
- 다음 단계를 포함하는 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트의 제조방법;A method for preparing polyhydroxyalkanoate containing phenyl lactate as a monomer, comprising the following steps;(a) 제10항 내지 제18항 중 어느 한 항의 재조합 미생물을 배양하여 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트를 생성시키는 단계; 및(a) culturing the recombinant microorganism of any one of claims 10 to 18 to produce a polyhydroxyalkanoate containing phenyllactate as a monomer; And(b) 상기 생성된 페닐락테이트를 단량체로 함유하는 폴리하이드록시알카노에이트를 수득하는 단계.(b) obtaining a polyhydroxyalkanoate containing the produced phenyl lactate as a monomer.
- 탄소원으로부터 아세틸-CoA 생성능을 가지는 미생물에서, 2-하이드록시이소카프로에이트-CoA 전이효소를 코딩하는 유전자, 폴리하이드록시알카노에이트 합성효소를 코딩하는 유전자, DAHP(3-데옥시-D-아라비노-헵툴로소네이트-7-인산) 합성효소를 코딩하는 유전자, 코리스메이트 뮤타아제/프레페네이트 디하이드로게네이즈를 코딩하는 유전자 및 D-락테이트 디하이드로게네이즈를 코딩하는 유전자, 하이드록시만델레이트합성효소를 코딩하는 유전자, 하이드록시만델레이트 산화효소를 코딩하는 유전자 및 D-만델레이트 탈수소효소를 코딩하는 유전자가 도입되어 있고, 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.In microorganisms having the ability to produce acetyl-CoA from a carbon source, a gene encoding 2-hydroxyisocaproate-CoA transferase, a gene encoding polyhydroxyalkanoate synthase, DAHP (3-deoxy-D-ara) Gene encoding the Vino-heptulsonate-7-phosphate) synthetase, gene encoding corismate mutase / prephenate dehydrogenase and gene encoding D-lactate dehydrogenase, hydroxy A gene encoding mandelate synthase, a gene encoding hydroxymandelate oxidase, and a gene encoding D-mandelate dehydrogenase are introduced, and polyhydroxyalkanoate containing mandelate as a monomer Recombinant microorganisms having the ability to produce.
- 제20항에 있어서, 상기 2-하이드록시이소카프로에이트-CoA 전이효소는 Clostridium difficile 630 유래의 hadA인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물. 21. The recombinant microorganism having polyhydroxyalkanoate producing ability according to claim 20, wherein the 2-hydroxyisocaproate-CoA transferase is hadA derived from Clostridium difficile 630.
- 제20항에 있어서, 상기 폴리하이드록시알카노에이트 합성효소는 Ralstonia eutropha, Pseudomonas, Bacillus 및 Pseudomonas sp. 6-19으로 구성된 군에서 선택되는 균주 유래의 PHA synthase 또는 하기에서 선택되는 아미노산 서열을 가지는 PHA synthase의 변이효소인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물:The method of claim 20, wherein the polyhydroxyalkanoate synthase is Ralstonia eutropha, Pseudomonas, Bacillus and Pseudomonas sp. PHA synthase derived from a strain selected from the group consisting of 6-19 or a mutant enzyme of PHA synthase having an amino acid sequence selected from the following. Recombinant having polyhydroxyalkanoate-producing ability containing a mandelate as a monomer microbe:서열번호 2의 아미노산 서열에서 E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K 및 Q481R로 구성되는 군으로부터 선택되는 하나 이상의 변이를 포함하는 아미노산 서열;An amino acid sequence comprising one or more variants selected from the group consisting of E130D, S325T, L412M, S477R, S477H, S477F, S477Y, S477G, Q481M, Q481K and Q481R in the amino acid sequence of SEQ ID NO: 2;서열번호 2의 아미노산 서열에서 E130D, S325T, L412M, S477G 및 Q481M이 변이된 아미노산 서열(C1335);Amino acid sequence (C1335) wherein E130D, S325T, L412M, S477G and Q481M are mutated in amino acid sequence of SEQ ID NO: 2;서열번호 2의 아미노산 서열에서 E130D, S477F 및 Q481K가 변이된 아미노산 서열(C1310); 및Amino acid sequence (C1310) wherein E130D, S477F and Q481K are mutated in the amino acid sequence of SEQ ID NO: 2; And서열번호 2의 아미노산 서열에서 E130D, S477F 및 Q481R이 변이된 아미노산 서열(C1312).The amino acid sequence of E130D, S477F and Q481R having a mutated amino acid sequence of SEQ ID NO: 2 (C1312).
- 제20항에 있어서, 상기 DAHP(3-데옥시-D-아라비노-헵툴로소네이트-7-인산) 합성효소를 코딩하는 유전자는 서열번호 8로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The gene encoding the DAHP (3-deoxy-D-arabino-heptulsonate-7-phosphate) synthase is a gene encoding an amino acid sequence represented by SEQ ID NO: 22. A recombinant microorganism having a polyhydroxyalkanoate generating ability containing a mandelate as a monomer.
- 제20항에 있어서, 상기 코리스메이트 뮤타아제/프레페네이트 디하이드로게네이즈를 코딩하는 유전자는 서열번호 9로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The polyhydrate containing mandelate as a monomer according to claim 20, wherein the gene encoding the corismate mutase / prephenate dehydrogenase is a gene encoding an amino acid sequence represented by SEQ ID NO: 9. Recombinant microorganism having the ability to produce oxyalkanoate.
- 제20항에 있어서, 상기 D-락테이트 디하이드로게네이즈를 코딩하는 유전자는 서열번호 10로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The polyhydroxyalkanoate containing mandelate as a monomer according to claim 20, wherein the gene encoding the D-lactate dehydrogenase is a gene encoding the amino acid sequence represented by SEQ ID NO: 10. Recombinant microorganisms having the ability to produce.
- 제20항에 있어서, 상기 하이드록시만델레이트합성효소를 코딩하는 유전자는 서열번호 11로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.21. The polyhydroxyalkanoate-producing ability according to claim 20, wherein the gene encoding the hydroxymandelate synthase is a gene encoding the amino acid sequence represented by SEQ ID NO: 11. Recombinant microorganisms.
- 제20항에 있어서, 상기 하이드록시만델레이트 산화효소를 코딩하는 유전자는 서열번호 12로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.21. The polyhydroxyalkanoate-producing ability of claim 20, wherein the gene encoding the hydroxymandelate oxidase is a gene encoding the amino acid sequence represented by SEQ ID NO: 12. Recombinant microorganisms.
- 제20항에 있어서, 상기 D-만델레이트 탈수소효소를 코딩하는 유전자는 서열번호 13으로 표시되는 아미노산 서열을 코딩하는 유전자인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.21. The polyhydroxyalkanoate-producing ability of claim 20, wherein the gene encoding the D-mandelate dehydrogenase is a gene encoding the amino acid sequence represented by SEQ ID NO: 13. Branched recombinant microorganism.
- 제20항에 있어서, 상기 D-락테이트 디하이드로게네이즈를 코딩하는 유전자는 fldH 유전자인 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.The recombinant microorganism having polyhydroxyalkanoate-producing ability according to claim 20, wherein the gene encoding the D-lactate dehydrogenase is a fldH gene.
- 제20항에 있어서, β-케토티올레이즈를 코딩하는 유전자와 아세토아세틸-CoA 리덕테이즈를 코딩하는 유전자가 추가로 도입되어 있는 것을 특징으로 하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트 생성능을 가지는 재조합 미생물.21. The polyhydroxyalkano containing monomer as a monomer according to claim 20, wherein a gene encoding β-ketothiolase and a gene encoding acetoacetyl-CoA reductase are further introduced. Recombinant microorganisms having the ability to produce.
- 다음 단계를 포함하는 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트의 제조방법;A method for preparing polyhydroxyalkanoate containing mandelate as a monomer comprising the following steps;(a) 제20항 내지 제30항 중 어느 한 항의 재조합 미생물을 배양하여 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트를 생성시키는 단계; 및(a) culturing the recombinant microorganism of any one of claims 20 to 30 to produce a polyhydroxyalkanoate containing mandelate as a monomer; And(b) 상기 생성된 만델레이트를 단량체로 함유하는 폴리하이드록시알카노에이트를 수득하는 단계.(b) obtaining a polyhydroxyalkanoate containing the produced mandelate as a monomer.
- 다음 단계를 포함하는 2-하이드록시이소카프로에이트, 2-하이드록시헥사노에이트 및 2-하이드록시옥타노에이트로 구성되는 군에서 선택되는 화합물을 단량체로 함유하는 폴리하이드록시알카노에이트의 제조방법;Method for producing polyhydroxyalkanoate containing as monomer a compound selected from the group consisting of 2-hydroxyisocaproate, 2-hydroxyhexanoate and 2-hydroxyoctanoate ;(a) 제1항 내지 제6항 중 어느 한 항의 재조합 미생물을 2-하이드록시이소카프로에이트, 2-하이드록시헥사노에이트 및 2-하이드록시옥타노에이트로 구성되는 군에서 선택되는 화합물을 함유하는 배지에서 배양하는 단계; 및(a) The recombinant microorganism of any one of claims 1 to 6 contains a compound selected from the group consisting of 2-hydroxyisocaproate, 2-hydroxyhexanoate and 2-hydroxyoctanoate. Culturing in a medium; And(b) 2-하이드록시이소카프로에이트, 2-하이드록시헥사노에이트 및 2-하이드록시옥타노에이트로 구성되는 군에서 선택되는 화합물을 단량체로 함유하는 폴리하이드록시알카노에이트를 수득하는 단계.(b) obtaining a polyhydroxyalkanoate containing as a monomer a compound selected from the group consisting of 2-hydroxyisocaproate, 2-hydroxyhexanoate and 2-hydroxyoctanoate.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/483,426 US10961521B2 (en) | 2017-02-28 | 2018-02-26 | Recombinant microorganism for producing polyhydroxyalkanoate |
CN201880014308.8A CN110382699B (en) | 2017-02-28 | 2018-02-26 | Methods of producing polyhydroxyalkanoates using 2-hydroxyisocaproate-CoA transferase |
EP18760488.9A EP3594350A4 (en) | 2017-02-28 | 2018-02-26 | METHOD OF PREPARING POLYHYDROXYAL CANOATE USING 2-HYDROXYISOCAPROATE-COA TRANSFERASE |
BR112019017457A BR112019017457A2 (en) | 2017-02-28 | 2018-02-26 | recombinant microorganism and method for the production of polyhydroxyalkanoate transferase |
JP2019545788A JP6854909B2 (en) | 2017-02-28 | 2018-02-26 | Method for producing polyhydroxyalkanoate using 2-hydroxyisocaproate-CoA transferase |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2017-0026266 | 2017-02-28 | ||
KR20170026266 | 2017-02-28 | ||
KR10-2017-0172899 | 2017-12-15 | ||
KR1020170172899A KR102036828B1 (en) | 2017-02-28 | 2017-12-15 | Method for Preparing Polyhydroxyalkanoates Using 2-Hydroxyisocaproate-CoA Transferase |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018159965A1 true WO2018159965A1 (en) | 2018-09-07 |
Family
ID=63370443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/002305 WO2018159965A1 (en) | 2017-02-28 | 2018-02-26 | Method for producing polyhydroxyalkanoate using 2-hydroxyisocaproate-coa transferase |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2018159965A1 (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292860A (en) | 1991-09-17 | 1994-03-08 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Copolymer and method for production thereof |
WO1998054329A1 (en) | 1997-05-28 | 1998-12-03 | Eidgenössische Technische Hochschule Zürich Institut Für Biotechnologie | Production of medium chain length poly-3-hydroxy alkanoates in escherichia coli, and monomers derived therefrom |
WO1999061624A2 (en) | 1998-05-22 | 1999-12-02 | Metabolix, Inc. | Polyhydroxyalkanoate biopolymer compositions |
US6143952A (en) | 1998-03-31 | 2000-11-07 | Regents Of The University Of Minnesota | Modified pseudomonas oleovorans phaC1 nucleic acids encoding bispecific polyhydroxyalkanoate polymerase |
WO2001055436A1 (en) | 2000-01-31 | 2001-08-02 | The Procter & Gamble Company | Medium chain length pha copolymer and process for producing same |
WO2008062996A1 (en) | 2006-11-21 | 2008-05-29 | Lg Chem, Ltd. | Copolymer containing 3-hydroxyalkanoate unit and lactate unit, and its manufacturing method |
KR101273599B1 (en) * | 2011-06-08 | 2013-06-11 | 한국화학연구원 | Method for Preparing Polyhydroxyalkanoate Containing 2-Hydroxybutyrate |
US20130288325A1 (en) * | 2010-11-03 | 2013-10-31 | The Regents Of The University Of California | Biofuel and chemical production by recombinant microorganisms via fermentation of proteinaceous biomass |
KR20150142304A (en) | 2014-06-11 | 2015-12-22 | 한국과학기술원 | Method for Fine-Tuning Gene Expression Using Synthetic Regulatory Small RNA |
-
2018
- 2018-02-26 WO PCT/KR2018/002305 patent/WO2018159965A1/en unknown
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292860A (en) | 1991-09-17 | 1994-03-08 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Copolymer and method for production thereof |
WO1998054329A1 (en) | 1997-05-28 | 1998-12-03 | Eidgenössische Technische Hochschule Zürich Institut Für Biotechnologie | Production of medium chain length poly-3-hydroxy alkanoates in escherichia coli, and monomers derived therefrom |
US6143952A (en) | 1998-03-31 | 2000-11-07 | Regents Of The University Of Minnesota | Modified pseudomonas oleovorans phaC1 nucleic acids encoding bispecific polyhydroxyalkanoate polymerase |
WO1999061624A2 (en) | 1998-05-22 | 1999-12-02 | Metabolix, Inc. | Polyhydroxyalkanoate biopolymer compositions |
WO2001055436A1 (en) | 2000-01-31 | 2001-08-02 | The Procter & Gamble Company | Medium chain length pha copolymer and process for producing same |
WO2008062996A1 (en) | 2006-11-21 | 2008-05-29 | Lg Chem, Ltd. | Copolymer containing 3-hydroxyalkanoate unit and lactate unit, and its manufacturing method |
US20130288325A1 (en) * | 2010-11-03 | 2013-10-31 | The Regents Of The University Of California | Biofuel and chemical production by recombinant microorganisms via fermentation of proteinaceous biomass |
KR101273599B1 (en) * | 2011-06-08 | 2013-06-11 | 한국화학연구원 | Method for Preparing Polyhydroxyalkanoate Containing 2-Hydroxybutyrate |
KR20150142304A (en) | 2014-06-11 | 2015-12-22 | 한국과학기술원 | Method for Fine-Tuning Gene Expression Using Synthetic Regulatory Small RNA |
Non-Patent Citations (25)
Title |
---|
AMOS, MCLNERNEY, ARCH. MICROBIOL., vol. 155, 1991, pages 103 |
BRANDL ET AL., INT. J. BIOL. MACROMOL., vol. 11, 1989, pages 49 |
DATABASE GenBank Database accession no. ACT66712.1 * |
DATABASE GenBank Database accession no. ANJ44374.1 * |
DATABASE GenBank Database accession no. CAA11761.1 * |
DATABASE NCBI Database accession no. NP 415275.1 * |
DATABASE NCBI Database accession no. WP_045540971.1 * |
DATSENKO, K. A. ET AL., PROC. NATL ACAD SCI. USA, vol. 97, 2000, pages 6640 |
DESMET ET AL., J. BACTERIOL., vol. 154, 1983, pages 870 - 78 |
DICKERT, S. ET AL., EUR. J. BIOCHEM., vol. 267, 2000, pages 3874 |
DOROSHENKO, V. G.: "Metabolic engineering of Escherichia coli for the production of phenylalanine and related compounds", APPLIED BIOCHEMISTRY AND MICROBIOLOGY, vol. 51, no. 7, December 2015 (2015-12-01), pages 733 - 750, XP055544354 * |
KANEKO, M. ET AL., J. BACTERIOL., vol. 185, 2003, pages 20 |
KIKUCHI, Y. ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 761 |
LANGENBACH ET AL., FEMS MICROBIOL. LETT., vol. 150, 1997, pages 303 |
LEE, S. Y., BIOTECHNOL. BIOENG., vol. 49, 1996, pages 1 |
NA, D. ET AL., NATURE BIOTECHNOL., vol. 31, 2013, pages 170 |
NEUMANN ET AL., EMBO J., vol. 1, 1982, pages 841 |
PARK, SJ ET AL., METAB. ENG., vol. 20, 2013, pages 20 |
QI ET AL., FEMS MICROBIOL. LETT., vol. 167, 1998, pages 89 |
RIBE, D. E. ET AL., J. BACTERIOL., vol. 127, 1976, pages 1085 |
See also references of EP3594350A4 * |
VACHIERI, S.G: "Crystal structure of the apo forms of Rhodotorula graminis D- mandelate dehydrogenase at 1.8A", PDB: 2W2K_A: CHAIN A , CRYSTAL STRUCTURE OF THE APO FORMS OF RHODOTORULA GRAMINIS D-MANDELATE DEHYDROGENASE AT 1.8A, 10 October 2012 (2012-10-10), XP009516488, DOI: 10.2210/pdb2W2K/pdb * |
YANG, JUNG EUN: "One-step fermentative production of aromatic polyesters from glucose by metabolically engineered Escherichia coli strains", NATURE COMMUNICATIONS, vol. 9, no. 79, 8 January 2018 (2018-01-08), pages 1 - 10, XP055544358, Retrieved from the Internet <URL:DOI:10.1038/s41467-017-02498-w> * |
YANG, T. H. ET AL., BIOTECHNOL. BIOENG., vol. 105, 2010, pages 150 |
ZHOU, H. Y. ET AL., BIORESOUR. TECHNOL., vol. 101, 2010, pages 4151 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011002220A2 (en) | Preparation method of lactate polymers and lactate copolymers using polyhydroxyalkanoate synthase mutants | |
WO2016153221A1 (en) | Mutant microorganism producing l-aspartic acid derivatives, and method for producing l-aspartic acid derivatives using same | |
WO2021215685A1 (en) | Low-temperature processible aliphatic polyester | |
WO2019203435A1 (en) | Novel promoter derived from organic acid-resistant yeast and method for expression of target gene by using same | |
WO2010090436A2 (en) | Recombinant ralstonia eutropha capable of producing polylactic acid or polylatic acid copolymer, and method for producing polylactic acid or polylatic acid copolymer using same | |
KR102036828B1 (en) | Method for Preparing Polyhydroxyalkanoates Using 2-Hydroxyisocaproate-CoA Transferase | |
US20100136637A1 (en) | Recombinant microorganism having a producing ability of polylactate or its copolymers and method for preparing polyactate or its copolymers using the same | |
WO2012169819A2 (en) | Method for producing polyhydroxyalkanoate containing 2-hydroxybutyrate as the monomer | |
KR101630003B1 (en) | Method of preparing for 2-hydroxyalkanoate polymer | |
WO2009157702A2 (en) | Method for preparing polylactate and copolymer thereof using a mutant microorganism with enhanced polylactate, and the copolymer producing capability thereof | |
EP1208208A2 (en) | Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) | |
KR101587618B1 (en) | Mutants Having a High Producing Ability of 4-Hydroxybutyrate and Preparing Method for 4-Hydroxybutyrate Using the Same | |
WO2013103246A2 (en) | Recombinant microorganism producing quinolinic acid and production method of quinolinic acid using same | |
US8669379B2 (en) | Microbial production of 3,4-dihydroxybutyrate (3,4-DHBA), 2,3-dihydroxybutyrate (2,3-DHBA) and 3-hydroxybutyrolactone (3-HBL) | |
WO2018159965A1 (en) | Method for producing polyhydroxyalkanoate using 2-hydroxyisocaproate-coa transferase | |
WO2020075943A1 (en) | Succinic acid-producing mutant microorganism into which high activity malate dehydrogenase is introduced, and method for preparing succinic acid by using same | |
WO2019004779A2 (en) | Novel o-succinyl homoserine transferase mutant and method for producing o-succinyl homoserine using same | |
WO2015060649A1 (en) | Microorganism producing o-succinyl homoserine and method for producing o-succinyl homoserine by using same | |
WO2011074842A2 (en) | Recombinant microorganism for producing polylactic acid or a polylactic acid copolymer from glycerol and method for producing polylactic acid or a polylactic acid copolymer from glycerol using the microorganism | |
WO2017131342A1 (en) | Recombinant microorganism having ability to produce poly(lactate-co-glycolate) or copolymer thereof from xylose and method for preparing poly(lactate-co-glycolate) or copolymer thereof by using same | |
KR100447532B1 (en) | (R)-Hydroxycarboxylic Acid Producing Recombinant Microorganism and Process for Preparing (R)-Hydroxycarboxylic Acid Using the Same | |
KR101685943B1 (en) | Transformant for producing 4-hydroxystyrene and its derivatives and method of producing thereof | |
KR101260187B1 (en) | Recombinant microorganism able to produce polylactate or polylactate copolymer from glycerol and method for producing polylactate or polylactate copolymer from glycerol using the same | |
WO2024117529A1 (en) | Novel variant polypeptide having propionaldehyde dehydrogenase activity and use thereof | |
WO2017126861A1 (en) | Recombinant mutant microorganisms having acrylic acid productivity and method for producing acrylic acid using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18760488 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019545788 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112019017457 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2018760488 Country of ref document: EP Effective date: 20190930 |
|
ENP | Entry into the national phase |
Ref document number: 112019017457 Country of ref document: BR Kind code of ref document: A2 Effective date: 20190821 |